unsubscribe from this list    update subscription preferences
View this email in your browser


On behalf of Regener8, we would like to wish all members and participants in our wider network a very happy and successful new year!  At the start of the 2016 we can look back with satisfaction on the achievements of last year – the delivery of a challenging programme track at MEIbioeng 2015, the strengthening of our early career researcher membership stream and the establishment of regenerative devices as a distinct product category to quote some examples. 

2016 promises the opportunity for academic and industry partners to work collaboratively with us in Proof of Concept projects to be run by our strategic alliance partners at the Medical Technologies Innovation and Knowledge Centre (IKC), our 9th Annual Conference (to be co-hosted this year with the IKC and held at the earlier date of 01 July) and a clearer emphasis on our role to facilitate the translation of regenerative devices to the clinic and the market.

We will continue to provide information on events and research and innovation news within the MedTech-RegenMed sector and signpost members to other stakeholders and potential collaborators.  We are committed to the establishment and support of a strong MedTech industry in the UK and the North of England in particular and look forward to contributing our resources and connections to further this aim in the year ahead.

John Fisher
Mike Raxworthy 


Regenerative Medicine journal publishes December workshop review

Mike Raxworthy, Regener8 Operations Director, took part in a workshop run by NICE, the University of Alberta, the Centre for Commercialization of Regenerative Medicine and the Cell Therapy Catapult in December 2014. A review of the workshop - "Bringing regenerative medicines to the clinic: the future for regulation and reimbursement" covers steps to be considered in assessing the true value of RegenMed products in order to bring them to clinical use. More info and download link on the Regener8 website.

Athersys strikes licensing deal with new Japanese partner

Japanese company Healios K.K. has bought exclusive rights to commercialise Athersys' stem cell technology for ischemic stroke patients in Japan. The deal also gives Healios the option to license MultiStem for use in other diseases - Acute Respiratory Distress Syndrome and an "orthopaedic area", according to a news release announcing the deal. Healios has also bought the right to incorporate MultiStem into its own technology for generating new organs.

Paper scaffolds for "origami-based" tissue engineering approach

An intriguing strategy for the formulation of hydrogel-laden scaffold structures using paper sheets for application to trachea tissue engineering has been published in PNAS.
When rabbit articular chondrocytes were encapsulated, the scaffold system was able to deliver biological cues in vivo.
The paper, by Kim et al is online here.

Industry trends and highlights 2015 - a review  

Events and trends in the stem cell / RegenMed / cell therapy industry in 2015 are published in a review by Alexey Bersenev. Regener8 members may be particularly interested in Highlight No 10: "Regulators and industry want to clarify autologous cell therapies".  
Read the whole review here.

Regener8's Ops Director appointed as RAEng Visiting Chair 

ReNeuron logo
Mike Raxworthy has been appointed as a Royal Academy of Engineering Visiting Professor in Medical Technology Innovation and Translation at the University of Leeds. This position runs alongside Mike's Regener8 role and his position as CEO of Neotherix.
Read more about Mike's new role here.

TETRA consortium wins €6.8m for replacement trachea trial 

The pan-European TETRA consortium, led by Regener8 member, Videregen, has been awarded 6.8m under the Horizon 2020 proramme for a pivotal Phase II clinical trial of the the company's tissue engineered replacement trachea.
Read the full story here


MeDe Innovation 2016 conference  - 28 January 2016    

Centre for Life, Newcastle

MeDe Innovation's 2016 conference will report on progress and advances in research, innovation and translation in three focus areas: New approaches of manufacturing at the point of need; Manufacturing regenerative devices, and Stratified design and manufacture of orthopaedic implants.  The event includes presentations, panel discussion networking opportunities and posters from industry, regulators, clinicians and academic researchers. Still time to book!

Tissue Engineering, Biofabrication and 3D-Bioprinting in Life Sciences  - 17-18 March 2016
Boston, USA

This conference brings together academic and industry stakeholders to discuss the importance of tissue engineering and 3D printing for achieving the potential of regenerative medicine, including 3D printing of tissues and organs. Keynote speakers, registration and further information on the conference website

Epigenetic Regulation of Skin Regeneration, Ageing and Disease - 17-19 March 2016 
Great Victoria Hotel, Bradford City Centre 

This international symposium brings together skin and chromatin biologists to further promote epigenetic research in skin biology and dermatology. The event will cover both basic and translational aspects of epigenetic research, including control of skin ageing, wound healing and inflammation.  Further info and registration. 

Inaugural UK Regenerative Medicine Conference  20-21 Sept 2016  
RIBA, Portland Place, London 

Save the date! The Cell Therapy Catapult and UK Regenerative Medicine Platform (UKRMP) will hold an inaugural conference in September 2016 at the Royal Institute of British Architects in central London. Further details to be confirmed, but the event will draw together leading players in the field and highlight outstanding research and advances from both the UK and internationally. Conference flyer here (PDF).


Do you have any news you would like to highlight to the Regener8 community?  We're keen to hear of your company/institute achievements, any funding calls, industry/sector news - please send details to Jo Kelly ( or upload directly to the Regener8 website.